DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Amphotericin B (Amphotericin B) - Respiratory Failure - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Respiratory Failure (7)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Amphotericin B where reactions include respiratory failure. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-11

Patient: 43 year old male

Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Device Related Infection, Death, Renal Failure, Sepsis Syndrome, Renal Impairment, Cardio-Respiratory Arrest, Cardiac Failure, Respiratory Failure, Hallucination, Visual, Neutropenia, Mycobacterium Fortuitum Infection, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ciprofloxacin HCL
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Clarithromycin
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Oseltamivir
    Dosage: 75 mg, 2x/day
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Immunosuppression

Amphotericin B
    Indication: Aspergillosis

Prednisolone
    Dosage: 60 mg, unk
    Indication: Immunosuppression

Ciprofloxacin HCL
    Dosage: 60 mg

Voriconazole
    Dosage: unk
    Indication: Aspergillosis

Teicoplanin
    Dosage: 400 mg, 1x/day
    Indication: Product Used FOR Unknown Indication

Meropenem
    Dosage: 1 g, 2x/day
    Indication: Product Used FOR Unknown Indication



Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-05

Patient: 43 year old male

Reactions: Liver Injury, Right Ventricular Failure, Dyspnoea, Haemoptysis, Cholestasis, Cardio-Respiratory Arrest, Sepsis Syndrome, Respiratory Failure, Aspergillosis, Neutropenia, Mycobacterium Fortuitum Infection, Renal Failure Acute, Influenza A Virus Test Positive

Adverse event resulted in: death

Drug(s) suspected as cause:
Prednisolone
    Dosage: 60 mg, daily
    Administration route: Oral
    Indication: Renal Vasculitis

Ciprofloxacin HCL
    Dosage: 500 mg, bid
    Indication: Mycobacterium Fortuitum Infection

Meropenem
    Dosage: 1 g, bid
    Indication: Sepsis Syndrome

Amikacin
    Indication: Mycobacterium Fortuitum Infection

Amphotericin B
    Indication: Aspergillosis

Prednisolone
    Indication: Pulmonary Vasculitis

Voriconazole
    Dosage: unk
    Indication: Aspergillosis

Cyclophosphamide
    Indication: Pulmonary Vasculitis

Oseltamivir
    Dosage: 75 mg, bid
    Indication: Sepsis Syndrome

Clarithromycin
    Dosage: 500 mg, bid
    Indication: Mycobacterium Fortuitum Infection

Teicoplanin
    Dosage: 400 mg, daily
    Indication: Sepsis Syndrome

Cyclophosphamide
    Dosage: 100 mg, daily
    Administration route: Oral
    Indication: Renal Vasculitis



Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30

Patient: 43 year old male

Reactions: Liver Injury, Device Related Infection, Death, Cardio-Respiratory Arrest, Mycobacterium Fortuitum Infection, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Sepsis Syndrome, Renal Failure, Renal Impairment, Cardiac Failure, Hallucination, Visual, Respiratory Failure, Neutropenia, Influenza

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Ciprofloxacin HCL
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Prednisolone
    Dosage: 60 mg, unk
    Indication: Immunosuppression

Oseltamivir
    Indication: Product Used FOR Unknown Indication

Teicoplanin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Immunosuppression

Clarithromycin
    Dosage: 500 mg, 2x/day
    Indication: Mycobacterium Fortuitum Infection

Voriconazole
    Dosage: unk
    Indication: Aspergillosis

Meropenem
    Indication: Product Used FOR Unknown Indication

Amphotericin B
    Indication: Aspergillosis



Possible Amphotericin B side effects in 43 year old male

Reported by a health professional (non-physician/pharmacist) on 2012-05-30

Patient: 43 year old male

Reactions: Bronchopulmonary Aspergillosis, Liver Injury, Haemoptysis, Neutropenic Sepsis, Device Related Infection, H1n1 Influenza, Renal Failure, Cardio-Respiratory Arrest, Hallucination, Visual, Cardiac Failure, Respiratory Failure, Mycobacterium Fortuitum Infection

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Teicoplanin (Teicoplanin)
    Indication: Product Used FOR Unknown Indication

Voriconazole
    Indication: Product Used FOR Unknown Indication

Clarithromycin
    Dosage: 1000 mg (500 mg, 2 in 1 d)
    Indication: Mycobacterium Fortuitum Infection

Prednisolone
    Dosage: 60 mg
    Indication: Immunosuppression

Oseltamivir Phosphate
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 100 mg (100 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Immunosuppression

Amphotericin B
    Indication: Aspergillosis

Ciprofloxacin
    Dosage: 1000 mg (500 mg, 2 in 1 d)
    Indication: Mycobacterium Fortuitum Infection

Meropenem
    Indication: Product Used FOR Unknown Indication



Possible Amphotericin B side effects in 47 year old female

Reported by a health professional (non-physician/pharmacist) from Brazil on 2012-03-08

Patient: 47 year old female, weighing 68.8 kg (151.4 pounds)

Reactions: Tachycardia, Hypokalaemia, Weight Increased, Hepatomegaly, Bronchospasm, Thrombocytopenia, Renal Failure Acute, Dyspnoea, Pneumonia, Mouth Haemorrhage, Anaemia, Pulmonary Haemorrhage, Urethral Haemorrhage, Retinoic Acid Syndrome, Renal Impairment, Diarrhoea, Respiratory Failure, Oliguria, Asthenia, Leukopenia, Infusion Related Reaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Fluconazole
    Dosage: 200 mg/day orally
    Administration route: Oral
    Indication: Candidiasis

Cytarabine
    Dosage: 370 mg/m2/day ev, for 7 days

Cefepime
    Dosage: 2 g every eight hours as empiric therapy, intravenous
    Indication: Febrile Neutropenia

Dipyrone INJ
    Dosage: 500 mg orally
    Administration route: Oral
    Indication: Febrile Neutropenia

ALL Transretinoic Acid (All Transretinoic Acid)
    Dosage: 40 mg/m2/day orally, 20 mg/m2/day orally
    Administration route: Oral
    Indication: Chemotherapy

Amphotericin B
    Dosage: 30 mg/day (6 hours of infusion), 240 mg (cumulative dose)
    Indication: Candidiasis

Mitoxantrone
    Dosage: 20 mg/m2/day ev, for 3 days
    Indication: Chemotherapy

Meropenem
    Dosage: 1 g ev, every eight hours



Possible Amphotericin B side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-08

Patient: female, weighing 25.7 kg (56.5 pounds)

Reactions: Pancreatitis Acute, Respiratory Failure, Disseminated Intravascular Coagulation, Acidosis, Cardiac Arrest, Blood Pressure Decreased, Anuria

Adverse event resulted in: death

Drug(s) suspected as cause:
Amphotericin B
    Dosage: see image
    Indication: Pneumonia
    Start date: 2010-03-01
    End date: 2010-04-06

Amphotericin B
    Dosage: see image
    Indication: Pneumonia
    Start date: 2010-04-07
    End date: 2010-04-12

Erythrocin
    Dosage: ([2 in 1 day, after breakfast and supper (200 mg, 2 in 1 day, after breakfast and supper)] oral)
    Administration route: Oral
    Indication: Primary Ciliary Dyskinesia
    Start date: 2005-01-01
    End date: 2010-04-12

Other drugs received by patient: Midazolam; Clobazam; Tazobactam; Gabapentin; Natural Aluminum Silicate; Monoammonium; Valproate Sodium; Carbocisteine Lysine; Budesonide; Teicoplanin; Clonidine HCL; Antibiotics-Resistant Lactic Acid Bacteriae; Albumin Tannate; Minocycline Hydrochloride; Phenobarbital TAB; Ambroxol Hydrochloride; Doripenem Monohydrate; Ethyl Loflazepate; Pranlukast; Sodium Bromide



Possible Amphotericin B side effects in female

Reported by a health professional (non-physician/pharmacist) from Japan on 2011-12-23

Patient: female, weighing 25.7 kg (56.5 pounds)

Reactions: Pancreatitis Acute, Vomiting, Disseminated Intravascular Coagulation, Acidosis, Heart Rate Decreased, Respiratory Failure, Abdominal Distension, Cardiac Arrest, Blood Pressure Decreased, Anuria

Adverse event resulted in: death

Drug(s) suspected as cause:
Amphotericin B
    Dosage: (100 mg intravenous (not otherwise specified) (100 mg qd intravenous (not otherwise specified)
    Indication: Pneumonia
    Start date: 2010-03-01

Amphotericin B
    Dosage: (100 mg intravenous (not otherwise specified) (100 mg qd intravenous (not otherwise specified)
    Indication: Pneumonia
    Start date: 2010-04-07
    End date: 2010-04-12

Erythrocin
    Dosage: (200 mg bid oral)
    Administration route: Oral
    Indication: Primary Ciliary Dyskinesia
    End date: 2010-04-12

Other drugs received by patient: Carbocisteine Lysine; Ambroxol Hydrochloride; Monoammonium Glycyrrhizinate; Gabapentin; Doripenem Monohydrate; Teicoplanin; Clobazam; Ethyl Loflazepate; Albumin Tannate; Antibiotics-Resistant Lactic Acid Bacteriae; Valproate Sodium; Minocycline Hydrochloride; Budesonide; Tazobactam; Phenobarbital TAB; Pranlukast; Sodium Bromide; Clonidine Hydrochloride; Natural Aluminum Silicate

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017